Yi Xiao
17Patents
2h-index
56Co-inventors
57Inventor score
Filing activity: Jun 4, 1999 → Apr 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7468459B2 | Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation | Performing Operations; Transporting | 25 | Expired |
| US6407241B1 | Process and intermediates for the preparation of imidazolidinone &agr;v integrin antagonists | Chemistry; Metallurgy | 15 | Expired |
| US9249168B2 | Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound | Chemistry; Metallurgy | 2 | Active |
| US8889869B2 | Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound | Chemistry; Metallurgy | 2 | Active |
| US6423845B1 | Process and intermediates to a tetrahydro-[1,8]- Naphthyridine | Chemistry; Metallurgy | 2 | Expired |
| US9255113B2 | Methods for the Preparation of HIV attachment inhibitor piperazine prodrug compound | Chemistry; Metallurgy | 1 | Active |
| US9243010B2 | Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound | Chemistry; Metallurgy | 1 | Active |
| US7495123B2 | Process for the preparation of enantiomerically enriched beta amino acid derivatives | Chemistry; Metallurgy | 1 | Expired |
| US6706885B2 | Process for preparing integrin antagonist intermediates | Chemistry; Metallurgy | 1 | Expired |
| US6646130B2 | Process to chiral integrin antagonist beta-amino acid intermediate | Chemistry; Metallurgy | 1 | Expired |
| US6069265A | Process for the synthesis of 1-aza-5-halo-5-stannabicyclo[3.3.3]undecane carbapenem intermediates | Chemistry; Metallurgy | 0 | Expired |
| US9394322B2 | Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound | Chemistry; Metallurgy | 0 | Active |
| US9403821B2 | Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound | Chemistry; Metallurgy | 0 | Active |
| US9376458B2 | Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound | Chemistry; Metallurgy | 0 | Active |
| US9518058B2 | Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide | Chemistry; Metallurgy | 0 | Active |
| US6194568A | Process for synthesizing carbapenem intermediates | Emerging Cross-Sectional Technologies | 0 | Expired |
| US12378246B2 | Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.